Shelli Farhadian1, Payal Patel2, Serena Spudich3. 1. Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, 367 Cedar Street, ESH Building A, Rm 311, New Haven, CT, 06510, USA. shelli.farhadian@yale.edu. 2. Department of Neurology, Yale School of Medicine, New Haven, CT, USA. 3. Department of Neurology, Division of Neurological Infections and Global Neurology and Center for Neuroepidemiology and Clinical Neurological Research, Yale School of Medicine, Yale University, New Haven, CT, USA.
Abstract
PURPOSE OF REVIEW: HIV-associated neurocognitive disorders (HAND) are common in patients with HIV disease, even during suppressive combination antiretroviral therapy (cART). This review article addresses the pathogenesis of HAND, focusing on important findings from the last 5 years. RECENT FINDINGS: While HIV-associated dementia is now rare in settings with cART availability, mild forms of HAND are increasing in prevalence. Biomarkers of cellular injury, such as neurofilament light chain and neopterin, can detect early stages of neuroinflammation associated with HIV infection and are increased even in asymptomatic individuals with chronic HIV infection. Several recent studies form a growing body of evidence that HIV can infect and replicate in monocytes and that blocking monocyte activity can potentially improve neurological outcomes in HIV. Early cART may also prevent HAND. Understanding the multifactorial causes of CNS infection and inflammation is critical to devising treatment and preventive strategies for HAND.
PURPOSE OF REVIEW: HIV-associated neurocognitive disorders (HAND) are common in patients with HIV disease, even during suppressive combination antiretroviral therapy (cART). This review article addresses the pathogenesis of HAND, focusing on important findings from the last 5 years. RECENT FINDINGS: While HIV-associated dementia is now rare in settings with cART availability, mild forms of HAND are increasing in prevalence. Biomarkers of cellular injury, such as neurofilament light chain and neopterin, can detect early stages of neuroinflammation associated with HIV infection and are increased even in asymptomatic individuals with chronic HIV infection. Several recent studies form a growing body of evidence that HIV can infect and replicate in monocytes and that blocking monocyte activity can potentially improve neurological outcomes in HIV. Early cART may also prevent HAND. Understanding the multifactorial causes of CNS infection and inflammation is critical to devising treatment and preventive strategies for HAND.
Authors: N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira Journal: Neurology Date: 2006-07-25 Impact factor: 9.910
Authors: Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton Journal: Neurology Date: 2014-05-09 Impact factor: 9.910
Authors: Susanna L Lamers; Rebecca Rose; Ekaterina Maidji; Melissa Agsalda-Garcia; David J Nolan; Gary B Fogel; Marco Salemi; Debra L Garcia; Paige Bracci; William Yong; Deborah Commins; Jonathan Said; Negar Khanlou; Charles H Hinkin; Miguel Valdes Sueiras; Glenn Mathisen; Suzanne Donovan; Bruce Shiramizu; Cheryl A Stoddart; Michael S McGrath; Elyse J Singer Journal: J Virol Date: 2016-09-29 Impact factor: 5.103
Authors: Frances L Wilkie; Karl Goodkin; Imad Khamis; Maria H van Zuilen; Diana Lee; Robert Lecusay; Mauricio Concha; Stephen Symes; Paola Suarez; Carl Eisdorfer Journal: J Acquir Immune Defic Syndr Date: 2003-06-01 Impact factor: 3.731
Authors: Serena S Spudich; Annelie C Nilsson; Nicole D Lollo; Teri J Liegler; Christos J Petropoulos; Steven G Deeks; Ellen E Paxinos; Richard W Price Journal: BMC Infect Dis Date: 2005-11-02 Impact factor: 3.090
Authors: Jenna B Honeycutt; William O Thayer; Caroline E Baker; Ruy M Ribeiro; Steven M Lada; Youfang Cao; Rachel A Cleary; Michael G Hudgens; Douglas D Richman; J Victor Garcia Journal: Nat Med Date: 2017-04-17 Impact factor: 53.440
Authors: Oliver M Grauer; Doris Reichelt; Ute Grüneberg; Hubertus Lohmann; Tilman Schneider-Hohendorf; Andreas Schulte-Mecklenbeck; Catharina C Gross; Sven G Meuth; Heinz Wiendl; Ingo W Husstedt Journal: Ann Clin Transl Neurol Date: 2015-08-18 Impact factor: 4.511
Authors: Matheus F Sathler; Michael J Doolittle; James A Cockrell; India R Nadalin; Franz Hofmann; Sue VandeWoude; Seonil Kim Journal: J Cell Sci Date: 2022-06-21 Impact factor: 5.235
Authors: Nithya Srinivas; Elias P Rosen; William M Gilliland; Martina Kovarova; Leila Remling-Mulder; Gabriela De La Cruz; Nicole White; Lourdes Adamson; Amanda P Schauer; Craig Sykes; Paul Luciw; J Victor Garcia; Ramesh Akkina; Angela D M Kashuba Journal: Xenobiotica Date: 2018-12-17 Impact factor: 1.908
Authors: Matias Jaureguiberry-Bravo; Jennifer Kelschenbach; Aniella Murphy; Loreto Carvallo; Eran Hadas; Lydia Tesfa; Travis M Scott; Monica Rivera-Mindt; Chinazo O Cunningham; Julia H Arnsten; David J Volsky; Joan W Berman Journal: J Leukoc Biol Date: 2020-06-24 Impact factor: 4.962
Authors: Jennifer O Lam; Craig E Hou; J Carlo Hojilla; Alexandra N Anderson; Paola Gilsanz; Stacey E Alexeeff; Tory Levine-Hall; Nicole Hood; Catherine Lee; Derek D Satre; Michael J Silverberg Journal: AIDS Date: 2021-04-01 Impact factor: 4.632